Tumor antigens are presented by the major histocompatibility complex (MHC) class I molecules on antigen-presenting cells (APCs) and recognized by CD8+ T cells, which differentiate into cytotoxic T lymphocytes under co-stimulation of CD4+ T cells. The gene discussed is CD8A; the disease is neoplasm.